International Journal of Drug Delivery Technology
Volume 15, Issue 2

Formulation and Development of Solifenacin Succinate Oral Suspension 

Prashant Deore*, Jayesh Dwivedi 

Department of Pharmaceutics (Pharmacy), Pacific Academy of Higher Education and  Research University, Udaipur, Rajasthan, 313 001, India

Received: 27th Mar, 2025; Revised: 29th Apr, 2025; Accepted: 5th Jun, 2025; Available Online: 25th Jun, 2025

ABSTRACT

Solifenacin succinate is prescribed for patients with overactive bladder (OAB) syndrome to address symptoms such as urge incontinence, increased urinary frequency, and urgency. Tablet formulations can be challenging or impossible to administer to patients who are unable or unwilling to swallow solid dosage forms like tablets or capsules. For these patients, a liquid formulation of Solifenacin succinate is a more suitable alternative. The goal was to develop a liquid formulation with reduced astringency and bitterness compared to Solifenacin succinate in its raw form, while ensuring good drug content homogeneity. A Solifenacin succinate suspension was developed and evaluated based on parameters including pH, density, viscosity, % assay, and drug release profile. Batch optimization was carried out using design of experiment (DoE) software. The optimized formulation was subjected to stability studies as per ICH guidelines. Trial batches played a crucial role in formulating the suspension. Suspending agent (MCC/CMC sodium), viscosity modifier (Xanthan gum) and sweetener (Xylitol) were considered as independent variables and viscosity, dissolution and content uniformity, the suspension batch was optimized with a desirability score of 0.63 using DoE software. The optimized batch demonstrated stability and successfully passed the stability tests. A stable oral suspension dosage form of the anti-muscarinic drug Solifenacin succinate was successfully developed, meeting pharmacopoeial standards and offering a patient-friendly alternative for those with difficulty swallowing solid dosage forms.

Key words: Quality by design, Quality target product profile, Critical quality attributes, Design of Experiment

How to cite this article: Prashant Deore, Jayesh Dwivedi. Formulation and Development of Solifenacin Succinate Oral Suspension. International Journal of Drug Delivery Technology. 2025;15(2):562-68. doi: 10.25258/ijddt.15.2.25

REFERENCESReferences

  1. Gibson M, editor. Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form. 2nd ed. Boca Raton: CRC Press; 2016. 560 p.
  2. Chambers Fox S. Remington Education Pharmaceutics. London and Chicago: Pharmaceutical Press; 2014. 47 p. (Remington Education).
  3. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. Lippincott Williams & Wilkins; 1986. 294,336,413;Vol. 3.
  4. Teja GD, Dasu CD, Srinivasa BP, Ravisankar. Quantitative analysis of solifenacin succinate in pharmaceutical dosage form using uv absorption spectroscopy. Journal of Chemical and Pharmaceutical Sciences. 2013;6(3):195–8.
  5. CH A kumar, T K kumar, Reddy G jyothi. Development, Formulation and Evaluation of Solifinacin Succinate Immediate Release Oral Tablets by Using Starch and HPMC. IJRPNS. 2013;2(1):91–100.
  6. Sudha RKVN, Kishore VS, Babu CV, Jitendranath E. Design, development and evaluation of solifenacin succinate tablets. Research Journal of Pharmaceutical Dosage Forms and Technology. 2015 Jun 28;7(2):111–7.
  7. Sk R, Srinivasababu P. Design, development and evaluation of solifenacin succinate modified release matrix tablets using natural polymer; 2014 [cited 2025 Jan 16]. Available from: https://www.semanticscholar.org/paper/design%2c-development-and-evaluation-of-solifenacin-sk-srinivasababu/a2521e6d168e633cc5e53151f483485af025a4af.
  8. Parveen R, Srinivasababu P; 2014. Design, development and evaluation of solifenacin succinate modified release matrix tablets using natural polymer. Medicine, materials science [Internet] [cited 2025 Jan 10]. Available from: https://www.semanticscholar.org/paper/design%2c-development-and-evaluation-of-solifenacin-sk-srinivasababu/a2521e6d168e633cc5e53151f483485af025a4af.
  9. Kumar M, Nanjappan K. RP-HPLC Method Development and Validation for Estimation of Solifenacin Succinate in Pharmaceutical Dosage Forms; 2021;Vol. 68.
  10. Abraham J; 2010. Handbook of transnational economic governance regimes [Internet]. Brill. In International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Tietje C, Brouder A, editor. Nijhoff [cited 2025 Feb 24]. Available from: https://brill.com/view/book/edcoll/9789004181564/Bej.9789004163300.i-1081_085.xml. 1041–53.